Timothy P Walbert Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Timothy P Walbert is Chairman, President and CEO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 616,772 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $71,853,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Timothy P Walbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2023	SELL Sale (or disposition) back to the issuer	$71,853,938 $116.5 p/Share	616,772 Reduced 100.0%	0 Ordinary Shares
Jan 05 2023	SELL Payment of exercise price or tax liability	$11,036,483 $113.24 p/Share	97,461 Reduced 13.65%	616,493 Ordinary Shares
Jan 05 2023	BUY Exercise of conversion of derivative security	-	219,995 Added 23.56%	713,954 Ordinary Shares
Jan 01 2023	SELL Payment of exercise price or tax liability	$5,276,337 $113.8 p/Share	46,365 Reduced 8.58%	493,959 Ordinary Shares
Jan 01 2023	BUY Exercise of conversion of derivative security	-	104,498 Added 16.21%	540,324 Ordinary Shares
Jun 03 2022	SELL Open market or private sale	$2,310,250 $92.41 p/Share	25,000 Reduced 5.43%	435,826 Ordinary Shares
Jun 03 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 5.15%	460,826 Ordinary Shares

May 31 2022	SELL Open market or private sale	$2,331,000 $93.24 p/Share	25,000 Reduced 5.43%	435,549 Ordinary Shares
May 20 2022	SELL Open market or private sale	$2,250,000 $90.0 p/Share	25,000 Reduced 5.15%	460,549 Ordinary Shares
May 20 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.9%	485,549 Ordinary Shares
May 11 2022	SELL Open market or private sale	$1,584,000 $90.0 p/Share	17,600 Reduced 3.68%	460,549 Ordinary Shares
May 11 2022	BUY Exercise of conversion of derivative security	$389,664 $22.14 p/Share	17,600 Added 3.55%	478,149 Ordinary Shares
May 06 2022	SELL Open market or private sale	$671,328 $90.72 p/Share	7,400 Reduced 1.58%	460,549 Ordinary Shares
May 06 2022	BUY Exercise of conversion of derivative security	$163,836 $22.14 p/Share	7,400 Added 1.56%	467,949 Ordinary Shares
May 02 2022	SELL Open market or private sale	$2,412,000 $96.48 p/Share	25,000 Reduced 5.15%	460,549 Ordinary Shares
Apr 22 2022	SELL Open market or private sale	$2,690,250 $107.61 p/Share	25,000 Reduced 4.9%	485,549 Ordinary Shares
Apr 22 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.67%	510,549 Ordinary Shares
Apr 08 2022	SELL Open market or private sale	$2,805,250 $112.21 p/Share	25,000 Reduced 4.9%	485,549 Ordinary Shares
Apr 08 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.67%	510,549 Ordinary Shares
Mar 30 2022	SELL Open market or private sale	$5,253,000 $105.06 p/Share	50,000 Reduced 9.34%	485,549 Ordinary Shares
Mar 25 2022	SELL Open market or private sale	$2,734,250 $109.37 p/Share	25,000 Reduced 4.46%	535,549 Ordinary Shares
Mar 25 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.27%	560,549 Ordinary Shares
Mar 11 2022	SELL Open market or private sale	$2,526,750 $101.07 p/Share	25,000 Reduced 4.46%	535,549 Ordinary Shares
Mar 11 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.27%	560,549 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$4,600,500 $92.01 p/Share	50,000 Reduced 8.54%	535,549 Ordinary Shares

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

IPSC

Century Therapeutics, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

SGMT

Sagimet Biosciences Inc.

Director

TPW